Pulmonology Book

http://www.fpnotebook.com/

Isoniazid

Aka: Isoniazid, INH
Advertisement
  1. Indications
    1. Tuberculosis Prophylaxis
    2. Multi-drug Tuberculosis Treatment regimen
  2. Background
    1. Structurally similar to Pyridoxine
    2. Interferes with formation of Mycobacteria cell walls
  3. Contraindications
    1. G6PD Deficiency
    2. Severe hepatic insufficiency (reduce INH dose)
  4. Dosing
    1. See Tuberculosis for specific dosing protocols and durations of treatment
    2. Daily dosing
      1. Adult: 300 mg PO or IM
      2. Child: 5 mg/kg (up to 300 mg daily)
    3. Intermittent dosing
      1. Adult: 900 mg orally twice weekly (15 mg/kg twice weekly)
  5. Adverse Effects: Hepatic
    1. Hepatotoxicity
      1. Subclinical Hepatitis: 10%
      2. Clinical Hepatitis: 1%
    2. Progressive liver damage
      1. Under age 20 years: rare
      2. Age 30 to 50 years: 1.5%
      3. Age over 50 years: 2.5%
    3. Common presenting symptoms of drug-induced hepatotoxicity
      1. Nausea or Vomiting
      2. Abdominal Pain (>50% of patients)
      3. Fever (10%)
      4. Rash (5%)
  6. Adverse Effects: Neurologic
    1. Peripheral Neuropathy
      1. See prevention below
    2. Insomnia
    3. Restlessness
    4. Muscle twitching
    5. Urinary Retention
    6. Seizures
    7. Psychosis
    8. Monoamine toxicity (MAO inhibitor-like reaction)
      1. Presents with Flushing
      2. Avoid concurrent aged cheese and wine
  7. Prevention: Peripheral Neuropathy
    1. Indications for concurrent Vitamin B6 supplementation (Neuropathy risks)
      1. Pregnancy
      2. Diabetes Mellitus
      3. Alcoholism
      4. Comorbid other Neuropathy
      5. Uremia
      6. Malnutrition
      7. HIV Infection
      8. Epilepsy
    2. Vitamin B6 (Pyridoxine)
      1. Pyridoxine 10 mg/day per 100 mg of INH
      2. Typical dose is 25-50 mg orally daily
  8. Drug Interactions
    1. Phenytoin
      1. INH Increases blood level and toxicity
  9. Monitoring
    1. Routine baseline Liver Function Tests not recommended
    2. Liver Function abnormalities exceed 3-5 times normal
    3. Obtain baseline and monthly Liver Function Tests if:
      1. History suggestive of Possible liver disorder
      2. Human Immunodeficiency Virus (HIV)
      3. Pregnancy
      4. Postpartum (within 3 months)
      5. Chronic Liver Disease
        1. Viral Hepatitis
        2. Alcoholic Hepatitis
        3. Cirrhosis
Medication Costs
ISONIAZID (on 2/10/2012 at Target.com)
ISONIAZID 300 MG Tablet #30 for $4.00 ($0.13/unit)
Isoniazid (on 2/9/2012 at DrugStore.com)
Isoniazid 100mg Tablets #30 for $13.99 ($0.47/unit)
Isoniazid 300mg Tablets #90 for $21.99 ($0.24/unit)
Isoniazid 50mg/5ml Syrup #473 for $77.14 ($0.16/unit)
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

isoniazid (C0022209)

Definition (CHV) Antibacterial agent used primarily as a tuberculostatic
Definition (CHV) Antibacterial agent used primarily as a tuberculostatic
Definition (MSH) Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
Definition (CSP) antibacterial agent used primarily as a tuberculostatic.
Definition (NCI) A synthetic derivative of nicotinic acid with anti-mycobacterial properties. Although its mechanism of action is still unclear, isoniazid appears to block the synthesis of mycolic acids, major components of the mycobacterial cell wall. This agent is only active against actively growing mycobacteria because, as a pro-drug, it requires activation in susceptible mycobacterial species. Isoniazid also interferes with mycobacterial metabolism of vitamin B6. Resistance occurs due to decreased bacterial wall penetration. (NCI04)
Definition (PDQ) A synthetic derivative of nicotinic acid with anti-mycobacterial properties. Although its mechanism of action is still unclear, isoniazid appears to block the synthesis of mycolic acids, major components of the mycobacterial cell wall. This agent is only active against actively growing mycobacteria because, as a pro-drug, it requires activation in susceptible mycobacterial species. Isoniazid also interferes with mycobacterial metabolism of vitamin B6. Resistance occurs due to decreased bacterial wall penetration. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39484&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39484&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C600" NCI Thesaurus)
Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH D007538
SnomedCT 387472004, 81335000
English Hydrazide, Isonicotinic Acid, Isoniazid, Isonicotinic Acid Hydrazide, 4-Pyridinecarboxylic acid, hydrazide, isonicotinyl hydrazine, Isonicotinyl Hydrazine, isoniazid (medication), isonicotinic acid hydrazide, ISONIAZID, Isoniazid [Chemical/Ingredient], inh, INA - Isoniazid, INAH - Isoniazid, INH, Isonicotinic acid hydrazide, Isonicotinylhydrazide, Isoniazid (product), Isoniazid (substance), isoniazid
Swedish Isoniazid
Czech isoniazid
Finnish Isoniatsidi
Russian IZONIAZID, IZONIKOTINOVOI KISLOTY GIDRAZID, ИЗОНИАЗИД, ИЗОНИКОТИНОВОЙ КИСЛОТЫ ГИДРАЗИД
Japanese イソニアジド, ピリジン-4-カルボヒドラジド, イソニコチン酸ヒドラジド
Spanish Hidracida del Ácido Isonicotínico, Hidrazida del Acido Isonicotinico, Isoniacida, Hidracida del Acido Isonicotinico, Isoniazida, Hidrazida del Ácido Isonicotínico, isoniacida (sustancia), isoniacida, isoniazida (producto), isoniazida (sustancia), isoniazida, isonicotinilhidrazina, ácido isonicotínco hidrazina
Polish Izoniazyd, Hydrazyd kwasu izonikotynowego
French Isoniazide
German Isoniazid, Isonicotinsäurehydrazid
Italian Isoniazide
Portuguese Hidrazida do Ácido Isonicotínico, Isoniazida
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Navigation Tree